Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Basal Cell 3Carcinoma, Squamous Cell 2Skin Neoplasms 1Eyelid Neoplasms 1Dermatofibrosarcoma 1Adenocarcinoma, Sebaceous 1

Interventions

pembrolizumab 3Ipilimumab 3Educational Status 3Biopsy 3Optical Imaging 2Nivolumab 2Early Intervention, Educational 2Ascorbic Acid 2methyl 5-aminolevulinate 1lavender oil 1four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1fludarabine phosphate 1fludarabine 1aldesleukin 1Zinc 1Water 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tomography, Optical Coherence 1Toll-Like Receptor 1 1Tea 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Semaxinib 1Second Harmonic Generation Microscopy 1Risk Factors 1Resistance Training 1Radiotherapy, Image-Guided 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Skin Neoplasms × Mohs Surgery × Clear all
NCT02373722 2018-07-03

Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery

Wake Forest University Health Sciences

Phase NA Completed
90 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡